TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
NVAX

Novavax Inc

Healthcare · Biotechnology

10.10$ +1.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Novavax Inc (NVAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -245 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow NVAX
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-67 -126 -255 -139 -185 -137 -43 323 -416 -714 -87 -245
4.4 6.0 8.5 9.8 8.2 5.7 4.9 13 29 41 48 28
6.1 13 19 20 18 17 128 184 130 85 48 36
5.5 14 20 23 11 13 112 176 574
5.1 7.2 -7.5 9.1 -21 -24 12 1,734 -361 -377 48 -888
7.3 18 18 4.2 1.4 1.9 55 57 93 59 13 5.6
-130 -21 28 36 29 38 -378 100 -93 -59 -204 -78
0.0 0.0 0.0 0.0 39
111 209 3.8 65 103 98 -39 590 -4.8
-0.8 -0.8 314 0.0 -96 -96 -96 -128 82 -352 -4.0 33
110 208 279 65 103 98 985 462 325 4.5 261 28
-87 61 51 -38 -53 0.2 567 880 -179 -765 -39 -289
-74 -144 -274 -143 -186 -138 -97 265 -509 -773 -100 -250

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?